Difference in blood lapatinib concentration under pre or post prandial fasting states in patients with breast cancer

Trial Profile

Difference in blood lapatinib concentration under pre or post prandial fasting states in patients with breast cancer

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Jul 2017

At a glance

  • Drugs Lapatinib (Primary)
  • Indications Breast cancer
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 10 Jul 2017 New trial record
    • 26 Jun 2017 Results published in the Annals of Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top